Cargando…
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes
Corneal transparency, necessary for vision and depending on the high organization of stromal extracellular matrix, is maintained by keratocytes. Severe or continuous corneal injuries determine exaggerated healing responses resulting in the formation of irreversible fibrotic scars and vision impairme...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737374/ https://www.ncbi.nlm.nih.gov/pubmed/36499651 http://dx.doi.org/10.3390/ijms232315325 |
_version_ | 1784847270313721856 |
---|---|
author | Rosa, Irene Fioretto, Bianca Saveria Romano, Eloisa Buzzi, Matilde Mencucci, Rita Marini, Mirca Manetti, Mirko |
author_facet | Rosa, Irene Fioretto, Bianca Saveria Romano, Eloisa Buzzi, Matilde Mencucci, Rita Marini, Mirca Manetti, Mirko |
author_sort | Rosa, Irene |
collection | PubMed |
description | Corneal transparency, necessary for vision and depending on the high organization of stromal extracellular matrix, is maintained by keratocytes. Severe or continuous corneal injuries determine exaggerated healing responses resulting in the formation of irreversible fibrotic scars and vision impairment. Soluble guanylate cyclase (sGC) stimulation demonstrated antifibrotic effects in both experimental fibrosis and human lung and skin fibroblasts. Here, we assessed whether sGC stimulation with BAY 41-2272 could attenuate transforming growth factor β1 (TGFβ1)-induced myofibroblast differentiation of human corneal keratocytes. Cells were challenged with TGFβ1, with/without BAY 41-2272 preincubation, and subsequently assessed for viability, proliferation, migration, chemoinvasion, as well for the expression of myofibroblast/fibroblast activation markers and contractile abilities. Treatment with BAY 41-2272 did not affect keratocyte viability, while preincubation of cells with the sGC stimulator was able to inhibit TGFβ1-induced proliferation, wound healing capacity, and invasiveness. BAY 41-2272 was also able to attenuate TGFβ1-induced myofibroblast-like profibrotic phenotype of keratocytes, as demonstrated by the significant decrease in ACTA2, COL1A1, COL1A2, FN1 and PDPN gene expression, as well as in α-smooth muscle actin, α-1 chain of type I collagen, podoplanin, vimentin and N-cadherin protein expression. Finally, BAY 41-2272 significantly counteracted the TGFβ1-induced myofibroblast-like ability of keratocytes to contract collagen gels, reduced phosphorylated Smad3 protein levels, and attenuated gene expression of proinflammatory cytokines. Collectively, our data show for the first time that BAY 41-2272 is effective in counteracting keratocyte-to-myofibroblast transition, thus providing the rationale for the development of sGC stimulators as novel promising modulators of corneal scarring and fibrosis. |
format | Online Article Text |
id | pubmed-9737374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97373742022-12-11 The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes Rosa, Irene Fioretto, Bianca Saveria Romano, Eloisa Buzzi, Matilde Mencucci, Rita Marini, Mirca Manetti, Mirko Int J Mol Sci Article Corneal transparency, necessary for vision and depending on the high organization of stromal extracellular matrix, is maintained by keratocytes. Severe or continuous corneal injuries determine exaggerated healing responses resulting in the formation of irreversible fibrotic scars and vision impairment. Soluble guanylate cyclase (sGC) stimulation demonstrated antifibrotic effects in both experimental fibrosis and human lung and skin fibroblasts. Here, we assessed whether sGC stimulation with BAY 41-2272 could attenuate transforming growth factor β1 (TGFβ1)-induced myofibroblast differentiation of human corneal keratocytes. Cells were challenged with TGFβ1, with/without BAY 41-2272 preincubation, and subsequently assessed for viability, proliferation, migration, chemoinvasion, as well for the expression of myofibroblast/fibroblast activation markers and contractile abilities. Treatment with BAY 41-2272 did not affect keratocyte viability, while preincubation of cells with the sGC stimulator was able to inhibit TGFβ1-induced proliferation, wound healing capacity, and invasiveness. BAY 41-2272 was also able to attenuate TGFβ1-induced myofibroblast-like profibrotic phenotype of keratocytes, as demonstrated by the significant decrease in ACTA2, COL1A1, COL1A2, FN1 and PDPN gene expression, as well as in α-smooth muscle actin, α-1 chain of type I collagen, podoplanin, vimentin and N-cadherin protein expression. Finally, BAY 41-2272 significantly counteracted the TGFβ1-induced myofibroblast-like ability of keratocytes to contract collagen gels, reduced phosphorylated Smad3 protein levels, and attenuated gene expression of proinflammatory cytokines. Collectively, our data show for the first time that BAY 41-2272 is effective in counteracting keratocyte-to-myofibroblast transition, thus providing the rationale for the development of sGC stimulators as novel promising modulators of corneal scarring and fibrosis. MDPI 2022-12-05 /pmc/articles/PMC9737374/ /pubmed/36499651 http://dx.doi.org/10.3390/ijms232315325 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rosa, Irene Fioretto, Bianca Saveria Romano, Eloisa Buzzi, Matilde Mencucci, Rita Marini, Mirca Manetti, Mirko The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title | The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title_full | The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title_fullStr | The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title_full_unstemmed | The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title_short | The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes |
title_sort | soluble guanylate cyclase stimulator bay 41-2272 attenuates transforming growth factor β1-induced myofibroblast differentiation of human corneal keratocytes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737374/ https://www.ncbi.nlm.nih.gov/pubmed/36499651 http://dx.doi.org/10.3390/ijms232315325 |
work_keys_str_mv | AT rosairene thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT fiorettobiancasaveria thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT romanoeloisa thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT buzzimatilde thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT mencuccirita thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT marinimirca thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT manettimirko thesolubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT rosairene solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT fiorettobiancasaveria solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT romanoeloisa solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT buzzimatilde solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT mencuccirita solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT marinimirca solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes AT manettimirko solubleguanylatecyclasestimulatorbay412272attenuatestransforminggrowthfactorb1inducedmyofibroblastdifferentiationofhumancornealkeratocytes |